February 8th, 2019

Nanovis Named Best Nanotechnology-Driven Implant Company for 2018

Elevate Ventures portfolio company recognized for its breakthrough technologies by Global Health and Pharma

INDIANAPOLIS – (Friday, February 8, 2019) – Elevate Ventures, a venture development organization, is proud to announce its portfolio company, Nanovis, was named ‘Best Nanotechnology-Driven Implant Company for 2018’ by Global Health and Pharma magazine.

As part of Global Health and Pharma’s Technology Awards 2018, which highlight innovative technology in the healthcare and pharmaceutical sectors, Nanovis is recognized for its breakthrough fixation and bactericidal technologies. Now in its third year, the awards are given to organizations and individuals solely on merit.

“Nanovis is truly moving the needle on technology for surgeons and hospitals, which in turn, results in better options and outcomes for patients,” said Chris LaMothe, CEO of Elevate Ventures.
“Nanovis is truly moving the needle on technology for surgeons and hospitals, which in turn, results in better options and outcomes for patients,” said Chris LaMothe, CEO of Elevate Ventures. “The Nanovis mission, combined with the talented team and breakthrough technologies, makes this recognition well-deserved. We are proud to call Nanovis an Elevate Ventures portfolio company and look forward to its continued success.”

Nanovis, founded in 2006, offers a wide portfolio of spinal implants with the most advanced fixation technology to surgeons and hospitals. This provides surgeons with the best aspects of fixation, visualization and durability. Nanovis is also working to add bactericidal capability to its fixation technologies.

“The award from Global Health and Pharma is a major validation of our mission to develop science-enhanced, life-improving technologies. We are incredibly honored,” said Matt Hedrick, CEO of Nanovis. “Since our inception in 2006, we have made tremendous progress to discover, license and launch the very best spinal implant technologies for fixation and infection, and we look forward to continually innovating for surgeons, hospitals and their patients.”

To learn more about Nanovis visit www.nanovisinc.com. To learn more about Elevate Ventures and its portfolio visit www.elevateventures.com.

Back to Top

Access Elevate Portals to